[{"address1": "1800 Owens Street", "address2": "Suite 900", "city": "San Francisco", "state": "CA", "zip": "94158", "country": "United States", "phone": "415 906 4324", "website": "https://www.vir.bio", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Vir Biotechnology, Inc., an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Its clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; collaboration with WuXi Biologics (Hong Kong) Limited and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. The company was incorporated in 2016 and is headquartered in San Francisco, California.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Marianne  De Backer M.B.A., M.Sc., Ph.D.", "age": 55, "title": "CEO & Director", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 4467539, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ann M. Hanly Ph.D.", "age": 53, "title": "Executive VP & Chief Technology Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 896072, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeff  Calcagno M.D.", "age": 63, "title": "Executive VP & Chief Business Officer", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 860494, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lawrence  Corey M.D.", "age": 76, "title": "Co-Founder & Scientific Advisor", "yearBorn": 1948, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Louis J. Picker M.D.", "title": "Co-Founder & Scientific Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jason  O'Byrne", "age": 56, "title": "Executive VP & CFO", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brent  Sabatini", "age": 50, "title": "Senior VP, Principal Accounting Officer & Chief Accounting Officer", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jennifer Eileen Towne Ph.D.", "title": "Executive VP & Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Vanina  de Verneuil J.D.", "title": "Executive VP, General Counsel & Corporate Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Arran  Attridge", "title": "Senior Vice President of Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 6, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.11, "open": 8.1, "dayLow": 7.8576, "dayHigh": 8.43, "regularMarketPreviousClose": 8.11, "regularMarketOpen": 8.1, "regularMarketDayLow": 7.8576, "regularMarketDayHigh": 8.43, "payoutRatio": 0.0, "beta": 0.632, "forwardPE": -2.2433157, "volume": 1400833, "regularMarketVolume": 1400833, "averageVolume": 2142725, "averageVolume10days": 1042630, "averageDailyVolume10Day": 1042630, "bid": 8.35, "ask": 8.39, "bidSize": 1, "askSize": 1, "marketCap": 1150629888, "fiftyTwoWeekLow": 6.56, "fiftyTwoWeekHigh": 14.45, "priceToSalesTrailing12Months": 15.506097, "fiftyDayAverage": 9.2341, "twoHundredDayAverage": 8.889075, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 333880736, "profitMargins": 0.0, "floatShares": 92173707, "sharesOutstanding": 137143008, "sharesShort": 7670907, "sharesShortPriorMonth": 7855176, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.0557, "heldPercentInsiders": 0.119969994, "heldPercentInstitutions": 0.76541, "shortRatio": 5.4, "shortPercentOfFloat": 0.0904, "impliedSharesOutstanding": 137143008, "bookValue": 8.399, "priceToBook": 0.9989285, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -521960000, "trailingEps": -3.83, "forwardEps": -3.74, "enterpriseToRevenue": 4.499, "enterpriseToEbitda": -0.622, "52WeekChange": -0.27524573, "SandP52WeekChange": 0.14239466, "quoteType": "EQUITY", "currentPrice": 8.39, "targetHighPrice": 31.0, "targetLowPrice": 14.0, "targetMeanPrice": 20.85714, "targetMedianPrice": 20.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 905347968, "totalCashPerShare": 6.61, "ebitda": -536606016, "totalDebt": 90139000, "quickRatio": 7.566, "currentRatio": 8.712, "totalRevenue": 74205000, "debtToEquity": 7.836, "revenuePerShare": 0.545, "returnOnAssets": -0.20803, "returnOnEquity": -0.38091, "grossProfits": -433139008, "revenueGrowth": -0.263, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -9.78616, "financialCurrency": "USD", "symbol": "VIR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1740781137, "regularMarketTime": 1740776400, "exchange": "NMS", "messageBoardId": "finmb_419881198", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "regularMarketChangePercent": 3.4525366, "regularMarketPrice": 8.39, "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "cryptoTradeable": false, "shortName": "Vir Biotechnology, Inc.", "longName": "Vir Biotechnology, Inc.", "fiftyDayAverageChange": -0.8441, "fiftyDayAverageChangePercent": -0.09141118, "twoHundredDayAverageChange": -0.49907494, "twoHundredDayAverageChangePercent": -0.05614475, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2142725, "fiftyTwoWeekLowChange": 1.8300004, "fiftyTwoWeekLowChangePercent": 0.27896348, "fiftyTwoWeekRange": "6.56 - 14.45", "fiftyTwoWeekHighChange": -6.0599995, "fiftyTwoWeekHighChangePercent": -0.41937712, "fiftyTwoWeekChangePercent": -27.524572, "earningsTimestamp": 1740603900, "earningsTimestampStart": 1746010740, "earningsTimestampEnd": 1746446400, "earningsCallTimestampStart": 1740605400, "earningsCallTimestampEnd": 1740605400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.83, "epsForward": -3.74, "epsCurrentYear": -3.40048, "priceEpsCurrentYear": -2.4672987, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1570800600000, "postMarketChangePercent": -0.476758, "postMarketPrice": 8.35, "postMarketChange": -0.04, "regularMarketChange": 0.2800007, "regularMarketDayRange": "7.8576 - 8.43", "displayName": "Vir Biotechnology", "trailingPegRatio": null, "__fetch_time": "2025-03-01"}]